Twelve-Month Outcomes of the Prospective, Multicenter, Single-Arm Study of the 355-nm Laser for Treatment of Below-the-Knee Arteries: Final Results of the Auryon BTK

The 355-mm laser has a high rate of freedom from TLR at 12-month with a significant improvement in RB categories, WIQ and quality of life (EQ-5D).Clinical ImpactThe Auryon BTK demonstrates the safety and effectiveness of the 355-nm Auryon laser system in treating infrapopliteal arterial disease in patients with critical limb ischemia yielding high freedom from TLR and improvement in quality of life despite complex disease. The Auryon laser can treat all lesion morphologies below the knee including severe calcium and needs to be considered by operators for vessel prepping prior to adjunctive balloon angioplasty.